Tech Company Financing Transactions

Revolution Medicines Funding Round

Revolution Medicines, based in Redwood City, scored $100 million from Boxer Capital, BVF Partners and Casdin Capital.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series C
Proceeds Purpose
Proceeds will support continued advancement of the company's pipeline, which includes programs addressing elusive targets within the RAS pathway such as KRASG12C(GTP) and other specific tumorigenic mutants of RAS.

Company Information

Company Status
Mailing Address
700 Saginaw Dr.
Redwood City, CA 94063
Email Address
Revolution Medicines (Nasdaq: RVMD) discovers and develops important new medicines for cancer patients by translating frontier oncology targets--proteins that drive the growth of cancers or that control immune responses that can defeat them.
Revolution Medicines LinkedIn Company Profile
Social Media
Revolution Medicines Company Twitter Account
Company News
Revolution Medicines News
Revolution Medicines on Facebook
Revolution Medicines on YouTube

Management Team

Email & Social
Chief Executive Officer
Mark Goldsmith
  Mark Goldsmith LinkedIn Profile  Mark Goldsmith Twitter Account  Mark Goldsmith News  Mark Goldsmith on Facebook
Chief Operating Officer
Margaret Horn
  Margaret Horn LinkedIn Profile  Margaret Horn Twitter Account  Margaret Horn News  Margaret Horn on Facebook
Vice President
Adrian Gill
  Adrian Gill LinkedIn Profile  Adrian Gill Twitter Account  Adrian Gill News  Adrian Gill on Facebook
Vice President
Richard Hansen
  Richard Hansen LinkedIn Profile  Richard Hansen Twitter Account  Richard Hansen News  Richard Hansen on Facebook
Vice President
Walter Reiher
  Walter Reiher LinkedIn Profile  Walter Reiher Twitter Account  Walter Reiher News  Walter Reiher on Facebook
Vice President
Jan Smith
  Jan Smith LinkedIn Profile  Jan Smith Twitter Account  Jan Smith News  Jan Smith on Facebook
Vice President
Xiaolin Wang
  Xiaolin Wang LinkedIn Profile  Xiaolin Wang Twitter Account  Xiaolin Wang News  Xiaolin Wang on Facebook
VP - Finance
Jack Anders
  Jack Anders LinkedIn Profile  Jack Anders Twitter Account  Jack Anders News  Jack Anders on Facebook
VP - Human Resources
Luan Wilfong
  Luan Wilfong LinkedIn Profile  Luan Wilfong Twitter Account  Luan Wilfong News  Luan Wilfong on Facebook
VP - R & D
Steve Kelsey
  Steve Kelsey LinkedIn Profile  Steve Kelsey Twitter Account  Steve Kelsey News  Steve Kelsey on Facebook



Browse more venture capital transactions:

Prev: 7/11/2019: TrustArc venture capital transaction
Next: 7/11/2019: Remitly venture capital transaction


Share this article


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary